Citadel Advisors »

Dexcom shares owned by Citadel Advisors

Quarter-by-quarter ownership of Dexcom shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Dexcom

Tip: Access up to 7 years of quarterly data

All positions including Dexcom held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dexcom by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $64M 61M 1.05
2023-09-30 $23M 25M 0.95

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Dexcom

Lazard Asset Management
Calamos Advisors
Citadel Advisors
Braidwell
MacKay Shields
Franklin Resources
Millennium Management
Man Group
Victory Capital Management
Shenkman Capital Management
Wellington Management Company
Pier 88 Investment Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Walleye Trading Advisors
Goldman Sachs Group

View all funds holding Dexcom